Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nelson

Showing results (1001-1010 of 1,126) with videos related to

Pageof 113
Sort By:
Acta Physiologica (Oxford, England)|September 28, 2019
Novel role of Tieg1 in muscle metabolism and mitochondrial oxidative capacitiesMalek Kammoun, Jerome Piquereau, Lydie Nadal-Desbarats, et al.
Cancer Research|January 2, 2009
Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcomeBrock C Christensen, E A Houseman, John J Godleski, et al.
Cancer Cell|June 11, 2024
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphomaClémentine Sarkozy, Shaocheng Wu, Katsuyoshi Takata, et al.
Scientific Reports|January 23, 2021
Loss of Parkinson's susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesisChandra Lebovitz, Nicole Wretham, Maryam Osooly, et al.
Plos One|October 17, 2008
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancerKaty Milne, Rebecca O Barnes, Adam Girardin, et al.
The Journal of Pathology|February 26, 2015
Recurrent genomic rearrangements in primary testicular lymphomaDavid D W Twa, Anja Mottok, Fong Chun Chan, et al.
Blood|September 13, 2011
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigensHelene Pere, Yves Montier, Jagadeesh Bayry, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemiaF C Barone, E A Irving, A M Ray, et al.
Nature Medicine|December 5, 2018
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancersWouter Scheper, Sander Kelderman, Lorenzo F Fanchi, et al.
Science Advances|February 1, 2021
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancerMarisa K Kilgour, Sarah MacPherson, Lauren G Zacharias, et al.
Pageof 113

Showing results (1001-1010 of 1,126) with videos related to

Sort By:
Pageof 113
Acta Physiologica (Oxford, England)|September 28, 2019
Novel role of Tieg1 in muscle metabolism and mitochondrial oxidative capacitiesMalek Kammoun, Jerome Piquereau, Lydie Nadal-Desbarats, et al.
Cancer Research|January 2, 2009
Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcomeBrock C Christensen, E A Houseman, John J Godleski, et al.
Cancer Cell|June 11, 2024
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphomaClémentine Sarkozy, Shaocheng Wu, Katsuyoshi Takata, et al.
Scientific Reports|January 23, 2021
Loss of Parkinson's susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesisChandra Lebovitz, Nicole Wretham, Maryam Osooly, et al.
Plos One|October 17, 2008
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancerKaty Milne, Rebecca O Barnes, Adam Girardin, et al.
The Journal of Pathology|February 26, 2015
Recurrent genomic rearrangements in primary testicular lymphomaDavid D W Twa, Anja Mottok, Fong Chun Chan, et al.
Blood|September 13, 2011
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigensHelene Pere, Yves Montier, Jagadeesh Bayry, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemiaF C Barone, E A Irving, A M Ray, et al.
Nature Medicine|December 5, 2018
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancersWouter Scheper, Sander Kelderman, Lorenzo F Fanchi, et al.
Science Advances|February 1, 2021
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancerMarisa K Kilgour, Sarah MacPherson, Lauren G Zacharias, et al.
Pageof 113